Latest filing published 16 Jun 2017 for PLx Pharma Inc., €45k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Filings by Gary L. Mossman span 2 companies, the busiest being Cambrex Corp and PLx Pharma Inc. Over a trading history stretching from 26 January 2005 to 14 June 2017, the count stands at 32 filings.
The open-market side counts 1 purchase for €45k alongside 19 sales for €2.5M. The net balance comes to €2.5M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 5 share grants and 6 option exercises. Since January 2017: 1 purchase and no sales on the market.
The record was last updated on 16 June 2017 with an open-market purchase (€45k) in PLx Pharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations